Skip to main content
. 2012 Nov 14;24(4):878–888. doi: 10.1093/annonc/mds579

Table 3.

First-line chemotherapy regimens in metastatic seminoma and non-seminoma

BEP (repeat cycles every 3 weeks)a reference [97]
Cisplatin 20 mg/m2 Day 1–5
Etoposide 100 mg/m2 Day 1–5
Bleomycin 30 mg Day 1, 8, 15
EP (repeat cycles every 3 weeks)b reference [33]
Cisplatin 20 mg/m2 Day 1–5
Etoposide 100 mg/m2 Day 1–5
VIP (repeat cycles every 3 weeks)c reference [98]
Cisplatin 20 mg/m2 Day 1–5
Etoposide 75 mg/m2 Day 1–5
Ifosfamide 1,2 g Day 1–5

aThree cycles BEP in IGCCCG ‘good prognosis’ patients; four cycles BEP in IGCCCG ‘intermediate prognosis’ and ‘poor prognosis’ patients.

bFour cycles EP only in IGCCCG ‘good prognosis’ patients with contraindications to bleomycin.

cFour cycles VIP only in IGCCCG ‘intermediate risk‘ and ‘poor risk’ patients with contraindications to bleomycin.

VIP, cisplatin, etoposide and ifosfamide.